Mix-up at Baltimore Johnson & Johnson plant delays delivery of COVID-19 vaccine dose
Employees at a Baltimore COVID-19 vaccine manufacturing plant are said to have mixed up ingredients weeks ago during the vaccine manufacturing process, effectively ruining nearly 15 million doses of the Johnson & Johnson vaccine, the New York Times first reported. Federal officials reportedly called the mix up at Maryland-based biopharmaceutical firm Emergent BioSolutions human error. Emergent BioSolutions is …
Mix-up at Baltimore Johnson & Johnson plant delays delivery of COVID-19 vaccine dose Read More »